phenoxybenzamine has been researched along with chloroethylnorapomorphine in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Baldessarini, RJ; Kula, NS; Law, SJ; Neumeyer, JL | 1 |
Arana, GW; Baldessarini, RJ; Kula, NS; Law, SJ; Neumeyer, JL | 1 |
2 other study(ies) available for phenoxybenzamine and chloroethylnorapomorphine
Article | Year |
---|---|
Aporphines. 30. (-)-N(2-chloroethyl)-10,11-dihydroxynor-aporphine (chloroethylnorapomorphine), a novel irreversible dopamine receptor antagonist.
Topics: Adenylyl Cyclase Inhibitors; Animals; Aporphines; Corpus Striatum; In Vitro Techniques; Phenoxybenzamine; Rats; Receptors, Dopamine | 1980 |
Chloroethylnorapomorphine, a proposed long-acting dopamine antagonist: interactions with dopamine receptors of mammalian forebrain in vitro.
Topics: Adenylyl Cyclases; Animals; Apomorphine; Aporphines; Cattle; Corpus Striatum; In Vitro Techniques; Phenoxybenzamine; Rats; Receptors, Dopamine | 1980 |